ADPT
#1508
Adaptive Biotechnologies Corporation - Common Stock
25.1 9 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.73%
Variación mensual
+10.00%
Variación en los últimos 6 meses
+62.41%
Cambio anual
+45.94%
Cierres anteriores
26.4 4
Open
25.1 9
Mínimo
25.1 9
Máximo
25.1 9
Volumen
151
Financials
- Market Capitalization 4.02 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-53.62
Relación precio/flujo de caja
10.99
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1474 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 57.86 USD | -4.36% | -3.20% | +5.49% | +180.06% | 4.24 B USD | ||
| 1493 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.77 USD | -3.35% | -2.04% | +0.97% | +424.30% | 4.11 B USD | ||
| 1518 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -13.01% | +253.10% | 3.94 B USD | ||
| 1532 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +71.22% | +277.61% | 3.87 B USD |